%20--%3e%3c!DOCTYPE%20svg%20PUBLIC%20'-//W3C//DTD%20SVG%201.1//EN'%20'http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd'%20[%20%3c!ENTITY%20st0%20'fill:%23267E9A;'%3e%3c!ENTITY%20st1%20'fill:%2378C9DA;'%3e%3c!ENTITY%20st2%20'fill:%23FFFFFF;'%3e%3c!ENTITY%20st3%20'fill:%23085580;'%3e%3c!ENTITY%20st4%20'fill:%2386C34A;'%3e%3c!ENTITY%20st5%20'fill:%232FBBCC;'%3e%3c!ENTITY%20st6%20'fill:%234C6F90;'%3e%3c!ENTITY%20st7%20'fill:%23194670;'%3e%3c!ENTITY%20st8%20'fill:%2307557E;'%3e%3c!ENTITY%20st9%20'fill:%23516E89;'%3e%20]%3e%3csvg%20version='1.1'%20id='Layer_1'%20xmlns='http://www.w3.org/2000/svg'%20xmlns:xlink='http://www.w3.org/1999/xlink'%20x='0px'%20y='0px'%20viewBox='0%200%2032%2032'%20style='enable-background:new%200%200%2032%2032;'%20xml:space='preserve'%3e%3cg%3e%3cg%3e%3crect%20x='10.3'%20y='14'%20style='&st5;'%20width='5'%20height='4.4'/%3e%3crect%20x='10.3'%20y='12'%20style='&st5;'%20width='11.4'%20height='1'/%3e%3crect%20x='16.4'%20y='14'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='15.8'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='17.5'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='16.4'%20y='19.3'%20style='&st5;'%20width='5.3'%20height='0.9'/%3e%3crect%20x='10.3'%20y='19.3'%20style='&st5;'%20width='5'%20height='0.9'/%3e%3cg%3e%3cpath%20style='&st5;'%20d='M22.6,22.3H9.4c-0.6,0-1.2-0.5-1.2-1.2v-10c0-0.6,0.5-1.2,1.2-1.2h13.1c0.6,0,1.2,0.5,1.2,1.2v10%20C23.7,21.7,23.2,22.3,22.6,22.3z%20M9.4,10.8c-0.1,0-0.3,0.1-0.3,0.3v10c0,0.1,0.1,0.3,0.3,0.3h13.1c0.1,0,0.3-0.1,0.3-0.3v-10%20c0-0.1-0.1-0.3-0.3-0.3H9.4z'/%3e%3c/g%3e%3c/g%3e%3cpath%20style='&st5;'%20d='M16,30.2C8.2,30.2,1.8,23.8,1.8,16S8.2,1.8,16,1.8S30.2,8.2,30.2,16S23.8,30.2,16,30.2z%20M16,2.8%20C8.7,2.8,2.8,8.7,2.8,16S8.7,29.2,16,29.2S29.2,23.3,29.2,16S23.3,2.8,16,2.8z'/%3e%3c/g%3e%3c/svg%3e)
Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
ESCRS News
10/21/2026
ESCRSIOLLaserMeetingNewsletterRefractiveSurgical
Lens-vs.-Laser Debate Heats Up at ESCRS Congress as New Refractive Technologies are Launched
The long-running debate between laser- and lens-based refractive surgery intensified at the 2026 ESCRS congress in London, where new product launches and packed scientific sessions underscored a ma...
10/21/2026
AIDealsDiagnosticESCRSMeetingNewsletter
Futures Forum Highlights Higher Investment Bar, Looks at AI Concerns
A common theme at the 2026 Ophthalmology Futures European Forum was that capital and innovation remain available, but the bar for both has risen. The forum was held Sept. 10 at Glaziers Hall on the...
10/21/2026
ESCRSMeetingNewsletter
ESCRS Congress Becomes Biggest International Ophthalmic Meeting
The 2026 congress of the European Society of Cataract and Refractive Surgeons (ESCRS) drew 17,717 attendees from more than 142 countries to London in the UK, setting a new record and making the con...
10/21/2026
AIESCRSMeetingNewsletter
ESCRS iNovation Day Spotlights Tech Boom and Barriers to Adoption
ESCRS iNovation Day showcased a broad pipeline of ophthalmic technologies, but companies expressed concerns over the economic climate. The forum was held Sept. 11, ahead of the ESCRS program in Lon...
10/21/2026
ESCRSMeetingNewsletterRefractiveSurgical
Excimer Laser Celebration Marks 40 Years of Refractive Surgery Innovation
The 2026 ESCRS congress marked 40 years of excimer laser technology in refractive surgery with its Excimer Laser Celebration. Hosted at the Excimer Laser Museum in the exhibition area, the event ho...
10/21/2026
ESCRSGlaucomaLaserMeetingNewsletter
Norlase Presents Early PMLT Results in Glaucoma Patients at ESCRS Congress
Alexander S. Thrane, MD, PhD, FEBOphth, presented initial clinical data for Norlase’s pattern microsecond laser trabeculoplasty (PMLT) treatment at the 2026 ESCRS congress, saying patients experien...
10/23/2025
ESCRSEuropeMeetingNewsletter
2025 ESCRS Congress Boasts Strong Attendance and Multiple Product Launches
More than 15 thousand people registered for the 2025 congress of the European Society of Cataract and Refractive Surgeons (ESCRS), held Sept. 12-16 at the Bella Center in Copenhagen, Denmark. Sixty...
10/23/2025
ESCRSEuropeInstrumentsMeetingNewsletterSingle-UseSurgical
ESCRS Roundtable Grapples with Impact of Cataract Surgery Waste
The state of sustainability in cataract surgery was the focus of a roundtable of regulatory professionals and leading surgeons at the 2025 meeting of the Euro-pean Society of Cataract and Refractiv...
10/23/2025
ESCRSEuropeGlaucomaLaserMIGSMeetingNewsletterSurgical
Attendees in Copenhagen Debate Whether Lasers Will Replace MIGS Stents
Panel sessions at the 2025 Ophthalmology Futures Forum and ESCRS Glaucoma Subspecialty Day brought together leading experts to debate the future of MIGS stents and whether lasers could emerge as a ...
10/23/2025
DiagnosticESCRSEuropeMeetingNewsletter
Digital Slit Lamp Technology Gains High Praise in Copenhagen
Slit lamps have remained largely unchanged for decades as optical-only devices that rely on physician drawings or written notes for documentation. Three innovations stood out at the 2025 Ophthalmol...
10/23/2025
ESCRSEuropeFLACSMeetingNewsletterRefractiveSurgical
ESCRS Celebrates 30 Years of Femtosecond Lasers in Ophthalmology
The European Society of Cataract and Refractive Surgeons paid tribute at its 2025 congress to the 30th anniversary of the first use of femtosecond lasers in ophthalmic surgery. Meeting organizers c...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.